Pharmacists in Oakland Township, MI Accepting Medicare
3 Pharmacists found. Showing 1 - 3
 Michelle Loree Bayer, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4816 N Adams Rd, Oakland Township, MI 48306 Phone: 248-276-5063 |
Jamie Harty, PHARMD Pharmacist - Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist Medicare: Not Enrolled in Medicare Practice Location: 4888 N Adams Rd, Oakland Township, MI 48306 Phone: 248-276-3261 Fax: 248-276-2584 |
 Michael R Young, R.PH. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3922 Briarbrooke Ln, Oakland Township, MI 48306 Phone: 248-804-4139 |
News Archive
Researcher uses short pulsed electric fields to preserve milk
Even though much of the population in developing countries is involved in agriculture, food security is virtually out of reach. Often the only resort is to purchase a cow, buffalo, or sheep, to provide a steady supply of fresh milk, a nutritious staple of a daily diet. But how to preserve it safely? Refrigeration and boiling are costly - and often impossible due to sporadic electricity.
FitBionic completes $2.2M funding round with KMG Capital Partners, CID4 and High Country Venture
FitBionic has completed a $2.2 million funding round with a team led by KMG Capital Partners, with High Country Venture and the Colorado Institute for Drug, Device and Diagnostic Development. The investment was developed in support of the global launch of FitBionic's currently available first product, the FitBionic Foot, and as a bridge to the company's Series A financing, which is expected in 2014.
Chardan initiates independent equity research coverage on StemCells
StemCells, Inc. announced today that Chardan Capital Markets (Chardan) initiated independent equity research coverage on the Company with a "Buy" recommendation and a 12-month price target of $1.45 per share. The new report, issued yesterday, was authored by Keay Nakae, Senior Analyst at Chardan.
USPTO Board of Patent Appeals rules in favor of Pacific Biosciences in case against Life Technologies
Pacific Biosciences of California, Inc. today announced that the Board of Patent Appeals and Interferences of the United States Patent and Trademark Office (USPTO) has rendered a decision in a previously announced patent interference provoked by Pacific Biosciences related to single molecule sequencing. The decision cancels all patent claims by Life Technologies Corporation involved in the interference.
› Verified 3 days ago